During the past decade, St. Louis Children's Hospital Eye Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Louis Children's Hospital Eye Center" #1 collaborator was "National Eye Institute (NEI)" with 2 trials as a collaborator and "Pediatric Eye Disease Investigator Group" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "St. Louis Children's Hospital Eye Center" are "Amblyopia" (2 trials). Many other conditions were trialed in "St. Louis Children's Hospital Eye Center" in a lesser frequency.

Most popular intervention types in "St. Louis Children's Hospital Eye Center" are "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Glasses" (1 trials), "Patching" (1 trials), "Spectacle correction" (1 trials) and "iPad®" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Louis Children's Hospital Eye Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "St. Louis Children's Hospital Eye Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in St. Louis Children's Hospital Eye Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St. Louis Children's Hospital Eye Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".